Immuron Limited (ASX:IMC) Announces Travelan® Clinical Trial Update
Immuron Limited announces positive Phase 2 results for Travelan®, with FDA submission pending and strong immunology findings.
Immuron Limited announces positive Phase 2 results for Travelan®, with FDA submission pending and strong immunology findings.
Vonex Limited announces CEO and Directors’ performance rights vesting, along with preliminary financial results for 1H FY25.
Southern Cross Gold Ltd (ASX:SXG) announces court approval for a scheme of arrangement with Southern Cross Gold Consolidated Ltd.
ADX Energy Ltd may face an interruption to Welchau-1 testing following an Austrian court ruling on environmental clearances.
First Graphene Limited (ASX:FGR) has temporarily paused trading in its securities pending further announcements.
EQ Resources Ltd announces Kevin MacNeill’s transition to CTO as part of a growth strategy, focusing on operational improvements.
Saturn Metals Limited reports key activities at Apollo Hill, navigating a challenging quarter while planning significant drilling and financial efforts.
Linius Technologies Limited announces the appointment of Ben Taverner as CEO to drive company growth and market share.
Atomo Diagnostics Limited (ASX:AT1) enters a five-year supply agreement with Newfoundland Diagnostics for its HIV self-testing products.
Highfield Resources (ASX:HFR) secures FIRB approval for Yankuang Energy’s US$376 million investment, facilitating key acquisitions.